Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
Peter Takacs,1 Urja Lathia,2 Janey Shin,2 Francois Nantel2 1Jan-Cil Hungary, Budapest, Hungary; 2Medical Affairs, Janssen Inc., Toronto, ON, Canada Background: The aim of the study was to compare drug survival rate of subcutaneous tumor necrosis factor alpha inhibitors in rheumatoid arthritis, ank...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-01-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/persistence-to-subcutaneous-biological-agents-in-hungarian-patients-tr-peer-reviewed-article-PPA |